Global DNA Sequencing in Drug Discovery Market Report 2026 | Capitalize on 12.5% CAGR as Illumina, Thermo Fisher, QIAGEN, and Oxford Nanopore Accelerate AI-Driven Precision R&D

Boost ROI through lower-cost assays, AI-driven analysis, local consumables production, supplier diversification, multiomics, and pharma-biotech partnerships.Dublin, Oct. 26, 2026 (GLOBE NEWSWIRE) -- "Deoxyribonucleic Acid (DNA) Sequencing in Drug Discovery Market Report 2026" has been added to ResearchAndMarkets.com's offering. DNA Sequencing in Drug Discovery Market to Reach $15.22 Billion by 2030 as Precision Medicine Advances The global deoxyribonucleic acid (DNA) sequencing in drug discovery